NCT01342120View on ClinicalTrials.gov

PHARMO Institute Seroquel Safety Study

CompletedOBSERVATIONAL
Enrollment

18,325

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
SchizophreniaMajor Depressive DisorderBipolar DisorderGeneralized Anxiety Disorder
Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
collaborator

PHARMO Institute for Drug Outcomes Research

UNKNOWN

lead

AstraZeneca

INDUSTRY